Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP”
USPTO PatentsView assignee record - 12 granted patents across 22 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Obschestvo ranks #23,118 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 22 technology areas.
- #23,118
- of 49,997 US assignees by volume
- Top 47%
- by Innovation Score (36.1/100)
- 11.1
- avg claims per patent
- +0%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R23118 · Foreign Corporation #23,118 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL
- GRANTS-MICRO 12 grants
- MID-PACK #23,118/49,997
- PHOTO-FINISH NuLabel
- CPC-FOCUS A61P · 22 areas
- INNOV-THIN 36.1/100
- CLAIMS-PAR 11.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-FLAT +0% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: NuLabel Technologies, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Obschestvo’s 36.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Obschestvo
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Marsupial Holdings · near
Marsupial Holdings · near
36 score
- Bioptigen · near
Bioptigen · near
36 score
- Medrx · near
Medrx · near
36 score
- Neofect · near
Neofect · near
36 score
- Obschestvo S… · this assignee
Obschestvo S… · this assignee
36 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Obschestvo's Innovation Score is 36.1/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Obschestvo?
Each dot is one of Obschestvo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Obschestvo’s own 11.1 claims/patent is at or below the 13.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Obschestvo's grants concentrate
Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP” is a focused PatentsView assignee: 22 CPC subclasses with 25% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2016. By volume, Obschestvo sits between NuLabel Technologies, Inc. and Omnimax International, LLC.
Obschestvo's three-year grant acceleration
Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP” shows 3 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Obschestvo's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Nulabel
NuLabel Technologies, Inc.
12 patents
- Numab Therapeutics
Numab Therapeutics AG
12 patents
- Nura Holdings Pty
Nura Holdings Pty Ltd
12 patents
- Nxera Pharma UK
Nxera Pharma UK Limited
12 patents
- OCM
OCM Inc.
12 patents
- Officine Maccafer…
Officine Maccaferri S.P.A.
12 patents
- Oleon
Oleon NV
12 patents
- Omnimax Internati…
Omnimax International, LLC
12 patents
- Obschestvo S Ogra… ◀
Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP”
12 patents
What this shows Obschestvo holds 12 patents at rank #23,110, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Obschestvo
By rank, the assignees closest to #23,110 in granted patent volume.
- NuLabel Technologies, Inc. #23,106 · 12 patents
- Numab Therapeutics AG #23,107 · 12 patents
- Nura Holdings Pty Ltd #23,108 · 12 patents
- Nxera Pharma UK Limited #23,109 · 12 patents
- OCM Inc. #23,111 · 12 patents
- Officine Maccaferri S.P.A. #23,112 · 12 patents
- Oleon NV #23,113 · 12 patents
- Omnimax International, LLC #23,114 · 12 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Obschestvo's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Obschestvo, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Obschestvo ranks #4,499 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (36 here).
Obschestvo's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
36 Top 47% higher than 53% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 8.3% |
| 2017 | 2 | 16.7% |
| 2018 | 1 | 8.3% |
| 2019 | 2 | 16.7% |
| 2020 | 3 | 25.0% |
| 2022 | 1 | 8.3% |
| 2024 | 2 | 16.7% |
Which technologies does Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP” patent most?
Top 15 of 22 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP”'s patent record in context - here's where to go next.
- Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP”'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 25% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #23,118 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP” against NuLabel Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 36.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.